Nikko Asset Management Americas’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.4M | Buy |
4,726,799
+456,779
| +11% | +$7.77M | 0.8% | 34 |
|
|
2025
Q1 | $83.3M | Buy |
4,270,020
+312,409
| +8% | +$6.09M | 1.07% | 25 |
|
|
2024
Q4 | $98.1M | Buy |
3,957,611
+404,782
| +11% | +$10M | 1.06% | 28 |
|
|
2024
Q3 | $87M | Buy |
3,552,829
+1,328,414
| +60% | +$32.5M | 0.99% | 26 |
|
|
2024
Q2 | $52.1M | Sell |
2,224,415
-137,402
| -6% | -$3.22M | 0.6% | 40 |
|
|
2024
Q1 | $77.9M | Buy |
2,361,817
+3,726
| +0.2% | +$123K | 0.77% | 37 |
|
|
2023
Q4 | $64.1M | Buy |
2,358,091
+715,911
| +44% | +$19.5M | 0.62% | 40 |
|
|
2023
Q3 | $39.5M | Buy |
1,642,180
+427,100
| +35% | +$10.3M | 0.47% | 48 |
|
|
2023
Q2 | $38.8M | Buy |
1,215,080
+556,514
| +85% | +$17.8M | 0.41% | 51 |
|
|
2023
Q1 | $19.9M | Sell |
658,566
-15,124
| -2% | -$458K | 0.23% | 60 |
|
|
2022
Q4 | $26.3M | Buy |
673,690
+162,759
| +32% | +$6.37M | 0.38% | 48 |
|
|
2022
Q3 | $23.8M | Buy |
510,931
+218,969
| +75% | +$10.2M | 0.3% | 59 |
|
|
2022
Q2 | $10.8M | Buy |
291,962
+8,453
| +3% | +$312K | 0.13% | 89 |
|
|
2022
Q1 | $16.3M | Buy |
283,509
+58,286
| +26% | +$3.35M | 0.12% | 88 |
|
|
2021
Q4 | $18M | Sell |
225,223
-29,132
| -11% | -$2.33M | 0.09% | 92 |
|
|
2021
Q3 | $22.1M | Buy |
254,355
+724
| +0.3% | +$63K | 0.1% | 96 |
|
|
2021
Q2 | $33M | Buy |
253,631
+24,230
| +11% | +$3.15M | 0.13% | 89 |
|
|
2021
Q1 | $18.4M | Buy |
229,401
+25,159
| +12% | +$2.01M | 0.09% | 108 |
|
|
2020
Q4 | $16.7M | Buy |
+204,242
| New | +$16.7M | 0.09% | 110 |
|